Your session is about to expire
← Back to Search
Cell Therapy
PSC-01 for Osteoarthritis
Phase 1
Waitlist Available
Research Sponsored by Personalized Stem Cells, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-4 months
Awards & highlights
Study Summary
The objective of this clinical study is to evaluate the safety of an intraarticular injection of an investigational biologic product (IBP), PSC-01, the patient's own adipose-derived stromal vascular fraction cells (SVF) extracted from a lipoaspirate sample, to treat the pain of osteoarthritis in a single knee. The secondary objective is to get initial data on efficacy of the PSC-01.
Eligible Conditions
- Osteoarthritis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of Adverse Events
Secondary outcome measures
Changes in KOOS Measurement
Trial Design
1Treatment groups
Experimental Treatment
Group I: PSC-01Experimental Treatment1 Intervention
All study participants will receive intraarticular injection of the investigational biological product, PSC-01.
Find a Location
Who is running the clinical trial?
Personalized Stem Cells, Inc.Lead Sponsor
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger